The HARTMANN GROUP, a leading European provider of system solutions for medical applications and care, will become the official hygiene partner of the Allianz Arena for the new 2021/2022 season. Spectators at future sporting events in the Allianz Arena will be offered even greater safety thanks to a holistic hygiene concept.

The coronavirus pandemic remains the dominant issue in the current financial year for HARTMANN's European core sales markets. The growth in sales seen over the course of the extraordinary year 2020, however, did not continue. Sales increases in the Infection Management segment compensated for a declining development in all other segments.

Michel Kuehn and Dr. Raymund Heinen set to retire and Stefan Grote appointed as Board Member for Incontinence Management.

Against the backdrop of the expected moderate sales growth, EBIT declined to EUR 104.4 million (previous year: EUR 123.2 million), in line with the forecast range. The challenges with respect to the earnings performance are strongly related to the difficult macroeconomic conditions within the markets as well as extensive regulatory...

Stefan Müller takes over the position of Chief Financial Officer (CFO) at PAUL HARTMANN AG as of July 1, 2020. The new CFO has many years of experience as CFO in various areas at ZEISS in Germany and the USA

The coronavirus pandemic was the defining issue for the HARTMANN GROUP in the first quarter of 2020. The business was strengthened during the period as a result of increased customer demand for disinfectants and protective equipment, as well as intensive measures to increase production capacities and the procurement of supplies despite...

Sales revenues in all segments are up on the previous year – above-average growth in Wound Management driven by innovations / EBIT at EUR 30.6 million virtually the same as last year (EUR 31.3 million) / Targets confirmed for the 2019 year as a whole – focus remains on strengthening competitive position and customer orientation

The HARTMANN GROUP, one of the leading international suppliers of medical and hygiene products, increased sales revenues by 3.7% to EUR 1.075 billion in the first half of 2019. All segments generated higher sales. The Wound Management segment has developed particularly dynamically and was an additional growth factor. With innovative wound care...

Focus on innovative strength, competitive strength and process efficiency. The HARTMANN GROUP is starting to implement a new five-year strategic program to strengthen its competitiveness and secure a leading international market position in the three core segments of Wound, Incontinence and Infection Management.

Hartmann moves to extend its product portfolio for advanced wound care with strategic investment in silicone technology and innovations // Safran Coating is one of Europe’s leading and most innovative suppliers of silicone technologies for healthcare, a main driver for growth in advanced wound care

• Solid growth in core medical segments: nine-month sales rise by 3.2 percent to EUR 1,563.9 million. • EBIT within expected range at EUR 90.3 million • 2018 outlook for sales and EBIT confirmed

The Supervisory Board of the HARTMANN GROUP today announced the appointment of Britta Fuenfstueck as the company’s new Chief Executive Officer and Chair of HARTMANN’s Management Board. Fuenfstueck will succeed Andreas Joehle, who has been in office since 2013 and announced last year his plans to step down due to personal reasons. She will join...

The HARTMANN GROUP remains on track for growth in its anniversary year 2018. Group sales revenues grew by 3.0% to EUR 1.0368 billion in the first six months, in spite of the continuing negative impact of exchange rates. If the strength of the euro had not led to reductions in revenue, especially in the case of America and Asia, the Group's...

The HARTMANN GROUP made a positive start in its anniversary year, 2018. Propelled by innovative product solutions and LINDOR's sales in the incontinence management segment, the Group's sales revenues rose to €516.0 million in the first quarter of 2018, an increase of 2.3 percent compared to the previous year. Without the negative impact of...

Heidenheim, Germany - November 7, 2017. In the first nine months of 2017, the HARTMANN GROUP, a leading international supplier of medical and healthcare products, succeeded in increasing its group sales revenues to EUR 1,514.7 million, a rise of 3.2% in relation to the prior year, despite difficult market conditions.

Heidenheim, Germany - September 4, 2017. Recognized for their remarkable contributions in wound care, the nominees for HARTMANN’s first LINK® Award were announced in anticipation of the LINK® Wound Healing Congress on Sept. 19th in Belfast. The congress will give health care professionals the opportunity to network and exchange knowledge on...

Heidenheim, Germany - August 9, 2017. In the first six months of 2017, the HARTMANN GROUP, a leading international supplier of medical and healthcare products, achieved sales revenues of EUR 1,006.8 million and exceeded the prior-year figure by 3.4%, thus passing the one billion mark for the first time ever within a half-year period. As...

Heidenheim, Germany - May 3, 2017. In the first quarter of 2017, the HARTMANN GROUP, a leading international supplier of medical and healthcare products, achieved a moderate rise of 4.5% in sales revenues to EUR 504.2 million. Meanwhile, all business segments exceeded their previous year's figure. EBIT showed a slight improvement to EUR 37.3...